NewsRelease
ebookDescribesthe Role of the InnateImmunityProteomeAsa Central Modulator of DiseasefromPandemicInfections toCancer
MONMOUTHJUNCTION, NJ, May7, 2020 -- Biotech Support Group reports on an ebook describinghow the innate immune response can be categorized and reported by newstrategies for proteomic analysis.
TheBSG ebook is entitled:
Thisebook describes the focus of BSG; how to address quantitativedifferences between proteins in blood samples representing achallenge or disease state, vs. samples representing a normal orcontrol state. For this purpose, BSG’s products and methods canhelp proteomic investigators explore all blood compartments.Furthermore, as unresolved inflammatory stimuli can lead to chronicdisease and pre-dispose individuals to severe acute responses, theebook describes new categorization strategies for selection of innateimmunity biomarker proteins. Finally, the ebook describes how pastproteomic analysis based on antigen recognition can lead toegregiously misleading information on the status of proteaseregulation in the general blood circulation.
“Proteomicsstarted with coverage annotation and Venn diagrams but now the fielddemands robust quantitation. This is so we can discover and validatenew biomarkers which are desperately needed to improve patientoutcomes, both in deciding the best standard of care with currenttherapies, but also to help develop personalized treatments in thefuture. For this, proteomics provides an essential technologyplatform. By adopting BSG’s products to enrich blood-derivedprotein biomarkers of low-abundance to mid-abundance, we can improvelinearity between targeted peptide LC-MS ion signals and proteinabundances.This can be done with consumable sample prep products thatare not based on immuno-affinity, creating simple and quantitativelyrobust workflows. As a result, the convergence of proteomictechnologies has made the task immediately available to understandthe role of the innate immunity proteome within the pathogenesis ofmany diseases from our current COVID-19 pandemic, to cancer andautoimmune disease.”,states Swapan Roy, Ph.D., President and Founder of Biotech SupportGroup.
Formore information on all of our consumable sample prep products,visit:
https://www.biotechsupportgroup.com/Products-a-z_a/258.htm
AboutBiotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, and HemogloBind™ and HemoVoid™ for hemoglobinremoval. From these innovations, the company has acquiredknowledgebase and biomarker intellectual property assets that supportdiscoveries of protein markers from blood, with special emphasis onearly detection and personalized medical decisions for cancerpatients. Formore information, go tohttp://www.biotechsupportgroup.com
ForBusiness Development, Contact:
MatthewKuruc 732-274-2866, [email protected]